Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,726,232
-
Share change
-
-737,502
-
Total reported value
-
$14,173,735
-
Price per share
-
$2.07
-
Number of holders
-
24
-
Value change
-
-$1,876,844
-
Number of buys
-
7
-
Number of sells
-
16
Institutional Holders of OBALON THERAPEUTICS INC - COM (OBLN) as of Q4 2018
As of 31 Dec 2018,
OBALON THERAPEUTICS INC - COM (OBLN) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,726,232 shares.
The largest 10 holders included
INTERWEST VENTURE MANAGEMENT CO, Tamarack Advisers, LP, C WorldWide Group Holding A/S, Vanguard Group Inc, HighTower Advisors, LLC, HOYLECOHEN, LLC, RENAISSANCE TECHNOLOGIES LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, GEODE CAPITAL MANAGEMENT, LLC, and BlackRock Inc..
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.